Hypertension trials recruiting in Kansas

All Hypertension trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Hutchinson, Kansas City, Wichita
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Wichita
• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
  NCT07333183 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Kansas: Kansas City
• A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
  NCT07175038 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Kansas: Kansas City
• A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
  NCT06822738 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · Kansas: Overland Park
• A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
  NCT07610278 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Wichita
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
  NCT06649110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Kansas: Kansas City
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
  NCT07365332 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Kansas City
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
  NCT06059638 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City, Wichita
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: El Dorado, Topeka, Wichita
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
  NCT07090161 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: El Dorado, Wichita
• External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
  NCT05889650 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: Kansas City
• Global Paradise System US Post Approval Study
  NCT06297291 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Wichita
• Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
  NCT06039176 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Kansas: Kansas City
• Hydrus® Microstent New Enrollment Post-Approval Study
  NCT04553523 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · Kansas: Overland Park
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
  NCT04624490 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Kansas City
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Kansas: Kansas City
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Pulmonary Hypertension Biorepository and Registry
  NCT04808596 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Reversing Glucose and Lipid-mediated Vascular Dysfunction
  NCT04832009 · Phase: Early Phase 1 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Kansas: Kansas City
• Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
  NCT04715022 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · Kansas: Kansas City
• Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
  NCT06626113 · Phase: Not specified · Ages: 18 Years to 79 Years · Sex: All (male and female) · Kansas: Kansas City
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Hutchinson, Kansas City, Topeka, Wichita